These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8969433)

  • 1. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
    Rayan GM; Parizi M; Tomasek JJ
    J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ; Vaughan MB; Haaksma CJ
    Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA
    Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
    Wong M; Mudera V
    J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
    Rayan GM; Tomasek JJ
    Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathobiology of Dupuytren's contracture: effects of prostaglandins on myofibroblasts.
    Hurst LC; Badalamente MA; Makowski J
    J Hand Surg Am; 1986 Jan; 11(1):18-23. PubMed ID: 3456001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.
    Tse R; Howard J; Wu Y; Gan BS
    BMC Musculoskelet Disord; 2004 Nov; 5(1):41. PubMed ID: 15541177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins influence myofibroblast contractility in Dupuytren's disease.
    Badalamente MA; Hurst LC; Sampson SP
    J Hand Surg Am; 1988 Nov; 13(6):867-71. PubMed ID: 3225412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
    Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
    J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.
    Moyer KE; Banducci DR; Graham WP; Ehrlich HP
    Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts.
    Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
    J Hand Surg Eur Vol; 2009 Dec; 34(6):783-7. PubMed ID: 19786408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemistry of Dupuytren's disease.
    Badalamente MA; Hurst LC
    Hand Clin; 1999 Feb; 15(1):35-42, v-vi. PubMed ID: 10050240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cultured bladder smooth muscle cells: assessment of in vitro contractility.
    Kropp BP; Zhang Y; Tomasek JJ; Cowan R; Furness PD; Vaughan MB; Parizi M; Cheng EY
    J Urol; 1999 Nov; 162(5):1779-84. PubMed ID: 10524934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture.
    Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE
    J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.